BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8801520)

  • 1. Immunosuppressive activity of hymenistatin I.
    Cebrat M; Wieczorek Z; Siemion IZ
    Peptides; 1996; 17(2):191-6. PubMed ID: 8801520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological studies on analogs of cyclolinopeptide A with a shortened peptide chain.
    Siemion IZ; Pedyczak A; Strug I; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):459-65. PubMed ID: 8572907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and immunosuppressive activity of glycine containing linear analogs of cyclolinopeptide A.
    Siemion IZ; Cebrat M; Pédyczak A; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):285-9. PubMed ID: 8010867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive activity of alanine analogs of cyclolinopeptide A.
    Wieczorek Z; Zimecki M; Pedyczak A; Lisowski M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):291-6. PubMed ID: 8010868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrazole analogues of cyclolinopeptide A: synthesis, conformation, and biology.
    Kaczmarek K; Jankowski S; Siemion IZ; Wieczorek Z; Benedetti E; Di Lello P; Isernia C; Saviano M; Zabrocki J
    Biopolymers; 2002 May; 63(6):343-57. PubMed ID: 11920436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive activity of cyclolinopeptide A.
    Wieczorek Z; Bengtsson B; Trojnar J; Siemion IZ
    Pept Res; 1991; 4(5):275-83. PubMed ID: 1802239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonated analogues of cyclolinopeptide A. Synthesis, immunosuppressive activity and CD studies.
    Cebrat M; Lisowski M; Siemion IZ; Zimecki M; Wieczorek Z
    J Pept Res; 1997 May; 49(5):415-20. PubMed ID: 9211222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Methylpseudoproline analogues of cyclolinopeptide A: Synthesis, structural analysis and evaluation of their suppressive effects in selected immunological assays.
    Katarzyńska J; Artym J; Kochanowska I; Jędrzejczak K; Zimecki M; Lisowski M; Wieczorek R; Piotrowski Ł; Marcinek A; Zabrocki J; Jankowski S
    Peptides; 2020 Oct; 132():170365. PubMed ID: 32622694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive activity of tyrosine analogues of cyclolinopeptide A.
    Wieczorek Z; Pedyczak A; Bodalski T; Lisowski M; Trojnar J; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):213-6. PubMed ID: 1300986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive activity in the series of cycloamanide peptides from mushrooms.
    Wieczorek Z; Siemion IZ; Zimecki M; Bolewska-Pedyczak E; Wieland T
    Peptides; 1993; 14(1):1-5. PubMed ID: 8441706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
    Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain.
    Wieczorek Z; Słoń J; Siemion IZ
    Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for new synthetic immunosuppressants II. Tetrazole analogues of hymenistatin I.
    Zubrzak P; Kociołek K; Smoluch M; Silberring J; Kowalski ML; Szkudlińska B; Zabrocki J
    Acta Biochim Pol; 2001; 48(4):1151-4. PubMed ID: 11995983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive activity of threonine-containing analogues of cyclolinopeptide A.
    Siemion IZ; Cebrat M; Lisowski M; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):257-61. PubMed ID: 1340179
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunomodulatory activity of tetra- and tripeptides of tuftsin-kentsin group.
    Wieczorek Z; Zimecki M; Słoń JJ; Siemion IZ
    Peptides; 1994; 15(2):215-21. PubMed ID: 8008626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and immunosuppressive activity of cyclolinopeptide A analogues containing homophenylalanine.
    Drygała P; Olejnik J; Mazur A; Kierus K; Jankowski S; Zimecki M; Zabrocki J
    Eur J Med Chem; 2009 Sep; 44(9):3731-8. PubMed ID: 19487056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential patterns of cyclosporine A-induced inhibition of humoral and cellular immune responses to sheep erythrocytes in mice.
    Zimecki M; Wieczorek Z
    Pol J Pharmacol; 2001; 53(5):495-500. PubMed ID: 11990068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclolinopeptides and their analogs--a new family of peptide immunosuppressants affecting the calcineurin system.
    Siemion IZ; Cebrat M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1999; 47(3):143-53. PubMed ID: 10470441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory activity of conformationally restricted peptides related to TGF-beta-2 90-99 sequence.
    Wieczorek Z; Słoń JJ; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):209-14. PubMed ID: 9017160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive activity of antamanide and some of its analogues.
    Siemion IZ; Pedyczak A; Trojnar J; Zimecki M; Wieczorek Z
    Peptides; 1992; 13(6):1233-7. PubMed ID: 1494502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.